Pourquoi le Tagrisso est-il si cher ? Découvrez les alternatives génériques au Tagrisso
In the last decade, lung cancer has advanced significantly, offering new hope to patients. The discovery of Osimertinib and its benefit in treating lung cancer is an important step towards improving survival rates. Developed by AstraZeneca under the brand name Tagrisso, has been a game-changer in improving survival rates, but...